Moberg Pharma AB (publ) (STO:MOB)
Sweden · Delayed Price · Currency is SEK 11.08
+0.14 (1.28%)
Aug 14, 2026, 5:29 PM CET
Moberg Pharma AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -21.62 | -27.24 | -255.11 | -21.09 | -15.71 | 7.49 |
Depreciation & Amortization | 1.61 | 1.61 | 1.32 | 2.1 | 2.58 | 2.58 |
Other Amortization | - | - | 300 | - | - | - |
Stock-Based Compensation | 4.94 | 5.69 | 4.72 | 2.31 | 1.46 | 0.63 |
Other Operating Activities | 5.1 | 3.22 | -65.36 | -4.36 | -3.8 | -27.46 |
Change in Accounts Receivable | -4.24 | -0.85 | -0.71 | 0.42 | -0.21 | 6.84 |
Change in Inventory | 3.75 | 0.72 | 2.82 | -7.12 | - | - |
Change in Other Net Operating Assets | -3 | -0.63 | -4.14 | -5.46 | -1.16 | -4.99 |
Operating Cash Flow | -13.45 | -17.49 | -16.47 | -33.21 | -16.84 | -15.3 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Acquisitions | - | - | - | - | - | -10 |
Sale (Purchase) of Intangibles | -27.1 | -43.19 | -73.55 | -124.12 | -68.07 | -31.31 |
Investing Cash Flow | -27.1 | -43.19 | -73.55 | -124.12 | -68.07 | -41.31 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -1.6 | -1.39 | -2.43 | -1.87 | -3.46 |
Total Debt Repaid | -1.64 | -1.6 | -1.39 | -2.43 | -1.87 | -3.46 |
Net Debt Issued (Repaid) | -1.64 | -1.6 | -1.39 | -2.43 | -1.87 | -3.46 |
Issuance of Common Stock | 0.83 | 0.83 | 335.52 | 100.64 | 109.68 | 133.44 |
Repurchase of Common Stock | -0.83 | -0.83 | - | -0.19 | - | - |
Other Financing Activities | -0.13 | -0.07 | -11.38 | -5.7 | - | - |
Financing Cash Flow | -1.77 | -1.66 | 322.76 | 92.33 | 107.81 | 129.97 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -42.32 | -62.34 | 232.73 | -65 | 22.9 | 73.37 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -13.45 | -17.49 | -16.47 | -33.21 | -16.84 | -15.3 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -80.23% | -129.18% | -167.87% | - | -8136.23% | - |
Free Cash Flow Per Share | -0.29 | -0.37 | -0.43 | -2.09 | -2.22 | -3.55 |
Levered Free Cash Flow | -42.18 | -54.27 | 27.25 | -149.44 | -65.28 | 40.32 |
Unlevered Free Cash Flow | -42.09 | -54.16 | 27.4 | -149.28 | -65.24 | 40.4 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.18 | 0.18 | 0.23 | 0.26 | 0.07 | 0.24 |
Change in Working Capital | -3.49 | -0.77 | -2.03 | -12.16 | -1.37 | 1.85 |